“Venetoclax and Azacitidine Combination Therapy in Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia” (2024) Annals of Leukemia Research, 5(1), pp. 19–24. doi:10.5281/zenodo.22227795.